Moxifloxacin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Moxifloxacin and local guidelines before prescribing.
Mechanism
Fluoroquinolone inhibiting DNA gyrase and topoisomerase IV.
Uses
Community-acquired pneumonia (second line), TB (second line), pelvic infection (specialist).
Dosing
- Doxycycline 100 mg twice daily for 7 days , then moxifloxacin 400 mg daily for 10 days (if macrolide resistance or status unknown).
Gynaecology: Sexual health - Moxifloxacin 400 mg for 10 days | Mycoplasma genitalium (after doxycycline); QT and tendon risks.
Gynaecology: Sexual health
Side effects
Tendinopathy, QT prolongation, C. difficile, aortic aneurysm, neuropsychiatric effects, hypoglycaemia.
Interactions
QT-prolonging drugs; corticosteroids increase tendon rupture risk; antacids reduce absorption.
Contraindications and cautions
Tendon disorder, QT prolongation, severe hepatic impairment
Monitoring
ECG, tendon pain
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Avoid in severe liver impairment
Overdose and reversal
Supportive
Special advice
Restricted to specialist guidance under MHRA warnings; stop at first tendon pain.
More from the textbook: uses, cautions and other points
- All-oral regimens built around newer drugs - bedaquiline , pretomanid and linezolid (with or without moxifloxacin) for 6 months (the "BPaL(M)" regimen) in many cases, or longer individualised regimens.
Respiratory: Infections - Side effects: QT prolongation (bedaquiline, moxifloxacin), and myelosuppression and neuropathy (linezolid).
Respiratory: Infections - Kidney impairment | No dose change usually - ceftriaxone, doxycycline, clindamycin, linezolid, moxifloxacin, metronidazole | Reduce - most penicillins and cephalosporins at low eGFR (seizures), aminoglycosides , vancomycin , aciclovir , co-trimoxazole, fluconazole; avoid nitrofurantoin if eGFR under 45
ID: How Infection Happens - All-oral regimens built around newer drugs — bedaquiline , pretomanid and linezolid (with or without moxifloxacin) for 6 months (the "BPaL(M)" regimen) in many cases, or longer individualised regimens.
Integrated respiratory chapter › 4.13 Drug-resistant TB - Multidrug-resistant TB (resistant to rifampicin and isoniazid) - specialist regimens (e.g. BPaLM: bedaquiline, pretomanid, linezolid ± moxifloxacin).
Microbiology: Bacteriology - structure, classification and important pathogens - DNA gyrase | Fluoroquinolones | Ciprofloxacin, levofloxacin, moxifloxacin | Ciprofloxacin - Gram-negatives including Pseudomonas; levofloxacin and moxifloxacin - respiratory
Microbiology: Diagnostic microbiology, antimicrobials and resistance
Where it is discussed in the book
- Respiratory: Infections (2 mentions)
- Gynaecology: Sexual health (2 mentions)
- ID: How Infection Happens (1 mention)
- Integrated respiratory chapter (2 mentions)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)